ABOUT MEDABLE
Medable’s mission is to get effective therapies to patients faster while expanding clinical research to every body, eliminating critical barriers to access such as income status, geography, & race. Medable offers a proven decentralized clinical trial platform that shortens trial timelines, creates operational efficiencies, and expands trial access to anyone worldwide using a combination of screening, eConsent, eCOA, ePRO, real-world data, connected sensors & more.
Founded by visionary CEO Dr. Michelle Longmire after discovering firsthand the difficulties of finding research patients, Medable’s platform is designed by a combination of clinicians, patients, and tech experts to ease the experience for all trial stakeholders. The result is over 150+ decentralized trials conducted across 60+ countries with over 1 million patients accessing our platform today.
A pioneer in patient-centric trials, Medable has been ranked the number one provider of decentralized clinical trials by the Everest Group, and recently collaborated with Tufts CSDD to release the first financial modeling showcasing the benefits of DCTs. Medable DCTs have now demonstrated net financial benefits of up to 5x & 14x greater than the initial upfront investment required for phase ll & phase lll studies, respectively. Additionally, our digital certification program has helped teach decentralized and patient-centric clinical trial methods to over 1,000+ of our industry peers.
Find out how Medable can partner with your organization to digitally transform your clinical protocols. Your research teams can experience benefits such as; improved patient experience, higher quality outcomes data, & savings of US$25,000,000+ for individual studies. Please visit www.Medable.com for further information.
FEATURED CONTENT
-
Discover how a pharmaceutical CRO addressed concerns about seizure diary timing in a rare disease study, leveraging insights from Medable's Patient Community Network to optimize data collection.
-
While clinical trials will always encounter challenges in driving quality experiences and data, there exists one approach that’s backed by regulatory agencies and proven to lead to better outcomes.
-
Check out a summary of the FDA’s guidance Framework for the Use of DHTs in Clinical Trials and what it means for sponsors and investigators using these innovative tools.
-
Consider this expedited review approach to facilitate the efficient evaluation of COAs and eCOAs, streamlining the pathway for successful trial execution.
-
Learn how this distinctive approach centered on enabling clinical trial sponsors to gather data and generate evidence ensures the successful acquisition of diverse information.
-
Review this year's predictions for improving digital biomarkers and data analytics, bettering endpoint sensitivity and specificity, and reducing timelines and costs of clinical development.
-
While technology plays a vital role in clinical trials, learn why it shouldn't overshadow the need for empathy, patient-centered care, and recognition of the individual behind the data.
-
Uncover the pre-built vaccine trial solution that delivers quality and predictability for your entire immunology portfolio.
-
ePRO and eCOA are helping to overcome oncology-specific challenges in clinical research. Find out how you can make life easier for patients when it matters most.
-
See how the core features of DCTs have become the new default clinical trial practices for a variety of therapeutic areas, almost four years after the 2020 pandemic brought about their rise.
-
Obtain a complete understanding of enrollment, screening, consent, and data collection by diving into this introductory handbook on decentralized clinical trials.
-
Uncover how artificial intelligence and machine learning could emerge as the most pivotal technologies of our era, with the potential to facilitate scalability in pharmaceuticals and other industries.
-
This example involves a top 10 pharmaceutical company and explores how they were able to improve oncology trial efficiency, safety, patient experience, and more using a platform approach.
-
See how digital solutions came together to enable faster study startup by 50% for this top pharma company conducting a Phase 3 diabetes study within the weight loss market.
-
See how digital solutions enabled this top pharma’s fastest clinical trial enrollment period of all time.
-
See why GSK, Syneos, and other top pharma entities are focused on a foundational digital platform approach for their future trials to deliver better patient experiences and outcomes.
-
Uncover why AI, ML, and clinical trial platforms have the potential to create true scalability across an organization's entire pipeline, and reduce timelines by YEARS.
-
There’s no doubt that 2023 will be remembered as the year that artificial intelligence and machine learning became mainstream. Gain an overview of the uses of AI and ML in clinical conduct.
-
Get an overview of draft perspectives and key points to reinforce decentralized clinical trial training, oversight, and risk assessment to guarantee a study's integrity, patient safety, and success.
-
Learn how digital solutions can contribute to a more participant-centered approach and potentially enhance the regulatory utility of PRO data while improving the overall quality and efficiency of oncology trials.
CONTACT INFORMATION
Medable
525 University Ave, Suite A70
Palo Alto, CA 94301
UNITED STATES
WEBINARS
-
Explore the benefits of incorporating consent management technology and discover practical strategies for developing effective change management and training programs.
-
Clinical trial technology has transformed the ways we can engage patients. Learn from experts at Uber Health and clinical tech companies how you can supercharge the patient experience with consumerization.
-
Industry experts discuss the concept of a trial platform as a service and how it can accelerate and enhance the day-to-day functions of clinical operations throughout the entire lifecycle of a study.
-
Listen to what sites have to say about the changing nature of COAs in clinical trials, including the usage of eCOA, its benefits, and ways to improve the technology.
-
<p>While the digital transformation of clinical trials has made tremendous strides in recent years, the plethora of new technologies can overwhelm. Learn how to help sites and sponsors combat the overload of technology.</p>
-
Today’s clinical trial participants anticipate that the convenience and flexibility they experience in their daily lives will be accommodated when entering a clinical trial. Learn how to keep participants engaged and compliant with your trial, using modern consumer experiences.
-
Watch as speakers discuss their joint efforts in implementing patient-centric digital trial solutions that harness the potential of RWD, translating it into actionable Real-World Evidence insights for a sponsoring client.
-
Learn how CROs, pharma, and biotechs are using digital trial methods to scale efficiencies across the entirety of their clinical trial portfolio for maximum ROI.
-
The most difficult clinical research just became more challenging. Learn tactics on how teams can simplify oncology research while solving new and old issues.
-
Did you know that the average cost for a delayed trial is between $600,000 and $8 million per day? Discover how electronic consent management technology is helping sponsors, CROs, and sites.
-
Learn how and why unified platforms are effective at delivering better patient access and shortening clinical trial timelines with this webinar.
-
Discover best practices and see real examples of how top pharmaceutical companies like GSK, Syneos, and others successfully drive the transformation of clinical development to achieve higher patient engagement and retention using digital technologies, all while emphasizing a foundational platform approach for their future trials.
-
Hear from young cancer survivor Dr. Lindsay Matt, and Medable SMEs as they document what challenges patients face in clinical trials, and how to help alleviate them with modern technology.
-
Research shows that the global DCT market will reach $14B by 2026. Research also suggests that up to 90% of clinical trials are at risk of failure. Faulty trial designs, patient retention, costs and flawed data collection are drivers for the failure rate in clinical trials. The risks of study failure are reduced by taking a patient- first enterprise platform approach.
-
In this on-demand webinar attendees will learn about the common misconceptions surrounding eConsent, as well as the benefits they can realize through a digitally-enabled approach.
-
This webinar provides insight into an understanding of hybrid and decentralized clinical trials (DCT), the facts and fiction around decentralized trials, and why decentralized trials are not an all or nothing approach.
-
Hear from industry experts on how they successfully combined agile eConsent technology with global regulatory expertise to increase enrollment rates and reduce both site and patient burden.
-
In this webinar, Medable SMEs take you through the end-to-end process of conducting decentralized clinical research, including benefits, common pitfalls and challenges, and more.
-
In this webinar, industry experts share their perspectives on how to address drug development challenges within cardiometabolic clinical studies and provide input on the impact of new regulatory guidance such as the DEPICT Act.
-
In this free webinar, learn how to update your clinical data strategy that ensures you can scale trials globally while decreasing the overall burden on sites and patients.
-
In this webinar, experts discuss how enriching oncology clinical trials with RWD generates deeper insights and improves operational efficiency to achieve better patient outcomes.
-
What does it take to get vaccine trials up and running quickly and efficiently? As it turns out, the best answer is DCT. Learn why in the available webinar.
FEATURED SOLUTIONS
-
Over the past year, this author has collaborated closely with a diverse team of clinicians and research experts to enhance Medable's research methodologies across various therapeutic domains.
-
Increased outreach, heightened involvement, superior quality. Tour this comprehensive consent management solution that enhances participant access and improves the overall patient experience.
-
Stay connected with your patients and their data by simplifying collection for sites and sponsors while keeping participants safe, comfortable, and engaged from any location.
-
Learn about our mission of making clinical trials easy to participate in around the world, as well as what Medable can do for you, with this overview.
-
Accelerate research and drive operational efficiencies with multi-modal, scalable digital solutions for oncology, vaccine, and cardiovascular / metabolic studies.
-
Explore an expertly crafted package of programs, products, and expertise addressing the unique challenges of vaccine research.
-
Medable eCOA is designed to enhance your decentralized trial capabilities with all features native to the platform. Modular by design, use what you need, not what you don’t.
-
Learn how to optimize patient access to clinical research with a modern eConsent platform that delivers an engaging, flexible and scalable user experience.
-
Limited access to clinical trials has had a direct impact on the development of new medicines. Explore Medable's vision to open scientific research to the world using a platform designed for everybody, every biology, everywhere.
-
Examine this factsheet to see how Medable’s oncology offering simplifies data collection for sites and sponsors while keeping patients safe, comfortable, and engaged from any location.